SAGE - Sage Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts17171718
Avg. Estimate-3.34-3.42-13.48-12.65
Low Estimate-3.6-3.97-14.18-15.77
High Estimate-2.75-2.78-13.09-8.94
Year Ago EPS-2.63-3.38-8.08-13.48
Revenue EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts18181919
Avg. Estimate3.23M9.32M13.53M105.17M
Low Estimate800k1.8M4.3M32.6M
High Estimate15M21.94M31M220.11M
Year Ago SalesN/A273k90.27M13.53M
Sales Growth (year/est)N/A3,313.90%-85.00%677.30%
Earnings History9/29/201812/30/20183/30/20196/29/2019
EPS Est.-2.42-2.92-3.25-3.33
EPS Actual-2.63-3.38-3.37-3.28
Difference-0.21-0.46-0.120.05
Surprise %-8.70%-15.80%-3.70%1.50%
EPS TrendCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Current Estimate-3.34-3.42-13.48-12.65
7 Days Ago-3.34-3.41-13.48-12.49
30 Days Ago-3.34-3.41-13.48-12.49
60 Days Ago-3.36-3.31-13.39-12.18
90 Days Ago-3.36-3.31-13.39-11.89
EPS RevisionsCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/A111
Growth EstimatesSAGEIndustrySectorS&P 500
Current Qtr.-27.00%N/AN/A-0.00
Next Qtr.-1.20%N/AN/A0.08
Current Year-66.80%N/AN/A-0.01
Next Year6.20%N/AN/A0.14
Next 5 Years (per annum)13.10%N/AN/A0.08
Past 5 Years (per annum)N/AN/AN/AN/A